|
🐜
|
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
24 auth.
J. Emile,
O. Abla,
S. Fraitag,
A. Horne,
J. Haroche,
J. Donadieu,
L. Requena-Caballero,
M. Jordan,
O. Abdel-Wahab,
C. Allen,
...
F. Charlotte,
E. Diamond,
R. Egeler,
A. Fischer,
Juana Gil Herrera,
J. Henter,
F. Janku,
M. Merad,
J. Picarsic,
C. Rodríguez-Galindo,
B. Rollins,
A. Tazi,
R. Vassallo,
L. Weiss
|
10 |
2016 |
10
🐜
|
|
🦁
|
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
23 auth.
J. Haroche,
F. Charlotte,
L. Arnaud,
A. von Deimling,
Z. Hélias‐Rodzewicz,
B. Hervier,
F. Cohen-Aubart,
D. Launay,
Annette Lesot,
K. Mokhtari,
...
D. Canioni,
L. Galmiche,
C. Rose,
M. Schmalzing,
S. Croockewit,
M. Kambouchner,
M. Copin,
S. Fraitag,
F. Sahm,
N. Brousse,
Z. Amoura,
J. Donadieu,
J. Emile
|
9 |
2012 |
9
🦁
|
|
🐢
|
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.
17 auth.
E. Diamond,
L. Dagna,
D. Hyman,
G. Cavalli,
F. Janku,
Juvianee I. Estrada-Veras,
M. Ferrarini,
O. Abdel-Wahab,
M. Heaney,
P. Scheel,
...
N. Feeley,
E. Ferrero,
K. McClain,
A. Vaglio,
T. Colby,
L. Arnaud,
J. Haroche
|
9 |
2014 |
9
🐢
|
|
🦁
|
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
13 auth.
J. Haroche,
F. Cohen-Aubart,
J. Emile,
L. Arnaud,
P. Maksud,
F. Charlotte,
P. Cluzel,
A. Drier,
B. Hervier,
Neila Benameur,
...
S. Besnard,
J. Donadieu,
Z. Amoura
|
9 |
2013 |
9
🦁
|
|
🐜
|
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
28 auth.
M. Pouletty,
C. Borocco,
N. Ouldali,
M. Caseris,
R. Basmaci,
N. Lachaume,
P. Bensaid,
S. Pichard,
Hanane Kouider,
G. Morelle,
I. Craiu,
C. Pondarré,
A. Dehò,
A. Maroni,
M. Oualha,
...
Z. Amoura,
J. Haroche,
J. Chommeloux,
F. Bajolle,
C. Beyler,
S. Bonacorsi,
G. Carcelain,
I. Koné-Paut,
B. Bader-Meunier,
A. Faye,
U. Meinzer,
C. Galeotti,
I. Melki
|
8 |
2020 |
8
🐜
|
|
🐜
|
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.
18 auth.
O. Abla,
E. Jacobsen,
J. Picarsic,
Z. Křenová,
R. Jaffe,
J. Emile,
B. Durham,
J. Braier,
F. Charlotte,
J. Donadieu,
...
F. Cohen-Aubart,
C. Rodríguez-Galindo,
C. Allen,
J. Whitlock,
S. Weitzman,
K. McClain,
J. Haroche,
E. Diamond
|
8 |
2018 |
8
🐜
|
|
🐜
|
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.
48 auth.
E. Diamond,
B. Durham,
J. Haroche,
Z. Yao,
Jing Ma,
S. Parikh,
Zhaoming Wang,
J. Choi,
Eunhee Kim,
F. Cohen-Aubart,
Stanley C. Lee,
Yijun Gao,
J. Micol,
Patrick K. Campbell,
M. Walsh,
...
B. Sylvester,
Igor Dolgalev,
Olga S. Aminova,
A. Heguy,
Paul Zappile,
J. Nakitandwe,
C. Ganzel,
J. Dalton,
D. Ellison,
Juvianee I. Estrada-Veras,
M. Lacouture,
W. Gahl,
P. Stephens,
V. Miller,
J. Ross,
Siraj M. Ali,
S. Briggs,
O. Fasan,
Jared G Block,
S. Héritier,
J. Donadieu,
D. Solit,
D. Hyman,
J. Baselga,
F. Janku,
B. Taylor,
Christopher Y. Park,
Z. Amoura,
A. Dogan,
J. Emile,
N. Rosen,
T. Gruber,
O. Abdel-Wahab
|
8 |
2016 |
8
🐜
|
|
🐢
|
CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.
28 auth.
L. Arnaud,
B. Hervier,
A. Néel,
M. Hamidou,
J. Kahn,
B. Wechsler,
G. Pérez-Pastor,
B. Blomberg,
J. Fuzibet,
François Dubourguet,
A. Marinho,
C. Magnette,
Violaine Noel,
M. Pavic,
J. Casper,
...
Anne-Bérangère Beucher,
N. Costedoat-Chalumeau,
L. Aaron,
J. Salvatierra,
C. Graux,
P. Cacoub,
V. Delcey,
C. Dechant,
P. Bindi,
C. Herbaut,
G. Graziani,
Z. Amoura,
J. Haroche
|
8 |
2011 |
8
🐢
|
|
🐜
|
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net
16 auth.
M. Girschikofsky,
M. Aricò,
D. Castillo,
A. Chu,
C. Doberauer,
J. Fichter,
J. Haroche,
G. Kaltsas,
P. Makras,
A. Marzano,
...
Mathilde de Menthon,
O. Micke,
E. Passoni,
H. Seegenschmiedt,
A. Tazi,
K. McClain
|
8 |
2013 |
8
🐜
|
|
🦁
|
Cardiovascular Involvement, an Overlooked Feature of Erdheim-Chester Disease: Report of 6 New Cases and a Literature Review
14 auth.
J. Haroche,
Z. Amoura,
É. Dion,
B. Wechsler,
N. Costedoat-Chalumeau,
P. Cacoub,
R. Isnard,
T. Généreau,
J. Wechsler,
Nina Weber,
...
C. Graef,
P. Cluzel,
P. Grenier,
J. Piette
|
8 |
2004 |
8
🦁
|
|
🦁
|
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
21 auth.
J. Haroche,
F. Cohen-Aubart,
J. Emile,
P. Maksud,
A. Drier,
D. Tolédano,
S. Barete,
F. Charlotte,
P. Cluzel,
J. Donadieu,
...
Neila Benameur,
P. Grenier,
S. Besnard,
J. Ory,
F. Lifermann,
A. Idbaih,
B. Granel,
B. Graffin,
B. Hervier,
L. Arnaud,
Z. Amoura
|
7 |
2015 |
7
🦁
|
|
🐜
|
Erdheim-Chester disease: Consensus recommendations for the evaluation, diagnosis, and treatment in the molecular era.
25 auth.
G. Goyal,
M. Heaney,
M. Collin,
F. Cohen-Aubart,
A. Vaglio,
B. Durham,
O. Hershkovitz-Rokah,
M. Girschikofsky,
E. Jacobsen,
Kazuhiro Toyama,
A. Goodman,
P. Hendrie,
Xin-xin Cao,
Juvianee I. Estrada-Veras,
O. Shpilberg,
...
A. Abdo,
M. Kurokawa,
L. Dagna,
K. McClain,
R. Mazor,
J. Picarsic,
F. Janku,
R. Go,
J. Haroche,
E. Diamond
|
7 |
2020 |
7
🐜
|
